ACCESSION: MSBNK-SMB_Measured-HSA032P0385002
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 71
COMMENT: RAW_SPEC {'RA19-pos_3689': {'bp': 132970.0, 'sum': 232652.0}, 'RA19-pos_3676': {'bp': 76836.0, 'sum': 112767.0}, 'HC21-pos_3400': {'bp': 9335.0, 'sum': 15794.0}, 'RA11-pos_3341': {'bp': 4052.0, 'sum': 9801.0}, 'RA17-pos_3569': {'bp': 15975.0, 'sum': 23148.0}, 'HC11-pos_3486': {'bp': 9491.0, 'sum': 14774.0}, 'HC3-pos_3794': {'bp': 38884.0, 'sum': 55371.0}, 'HC15-pos_3562': {'bp': 12109.0, 'sum': 19459.0}, 'HC17-pos_3417': {'bp': 44326.0, 'sum': 63234.0}, 'HC9-pos_3475': {'bp': 9909.0, 'sum': 15884.0}, 'HC20-pos_3637': {'bp': 4124.0, 'sum': 6201.0}, 'RA5-pos_3692': {'bp': 11172.0, 'sum': 18579.0}, 'HC12-pos_3647': {'bp': 7253.0, 'sum': 12192.0}, 'HC18-pos_3422': {'bp': 70823.0, 'sum': 114563.0}, 'RA24-pos_3260': {'bp': 3031.0, 'sum': 9214.0}, 'HC23-pos_3419': {'bp': 2179.0, 'sum': 6238.0}, 'RA12-pos_3708': {'bp': 15619.0, 'sum': 23991.0}, 'HC1-pos_3582': {'bp': 3990.0, 'sum': 8125.0}, 'QC7-pos_3413': {'bp': 4948.0, 'sum': 9349.0}, 'HC13-pos_3689': {'bp': 3311.0, 'sum': 5103.0}, 'HC14-pos_3553': {'bp': 5955.0, 'sum': 14045.0}, 'HC24-pos_3367': {'bp': 13326.0, 'sum': 22352.0}, 'HC2-pos_3575': {'bp': 12896.0, 'sum': 20051.0}, 'HC26-pos_3524': {'bp': 8242.0, 'sum': 17539.0}, 'QC8-pos_3397': {'bp': 3773.0, 'sum': 11071.0}, 'HC25-pos_3497': {'bp': 9599.0, 'sum': 14296.0}, 'HC17-pos_3403': {'bp': 18321.0, 'sum': 31406.0}, 'RA15-pos_3664': {'bp': 13274.0, 'sum': 19399.0}, 'QC5-pos_3428': {'bp': 4842.0, 'sum': 11382.0}, 'HC2-pos_3584': {'bp': 15371.0, 'sum': 24009.0}, 'RA2-pos_3688': {'bp': 5740.0, 'sum': 9839.0}, 'RA25-pos_3455': {'bp': 13081.0, 'sum': 26325.0}, 'RA6-pos_3339': {'bp': 9132.0, 'sum': 14144.0}, 'QC4-pos_3462': {'bp': 8421.0, 'sum': 13930.0}, 'HC10-pos_3496': {'bp': 15693.0, 'sum': 26191.0}, 'RA26-pos_3383': {'bp': 4210.0, 'sum': 13692.0}, 'HC22-pos_3429': {'bp': 12708.0, 'sum': 20135.0}, 'QC3-pos_3445': {'bp': 6063.0, 'sum': 15248.0}, 'RA23-pos_3433': {'bp': 5743.0, 'sum': 13137.0}, 'QC2-pos_3431': {'bp': 4033.0, 'sum': 9829.0}, 'HC22-pos_3436': {'bp': 18729.0, 'sum': 31579.0}, 'QC1-pos_3371': {'bp': 5537.0, 'sum': 9074.0}, 'HC16-pos_3709': {'bp': 21547.0, 'sum': 34604.0}, 'RA20-pos_3508': {'bp': 6133.0, 'sum': 9910.0}, 'RA13-pos_3470': {'bp': 5283.0, 'sum': 7584.0}, 'RA16-pos_3446': {'bp': 3698.0, 'sum': 6324.0}, 'RA22-pos_3320': {'bp': 7786.0, 'sum': 15177.0}, 'RA9-pos_3296': {'bp': 6252.0, 'sum': 12393.0}, 'RA6-pos_3350': {'bp': 9184.0, 'sum': 17023.0}, 'RA2-pos_3663': {'bp': 3404.0, 'sum': 5740.0}, 'HC8-pos_3466': {'bp': 7116.0, 'sum': 13423.0}, 'RA16-pos_3430': {'bp': 550.0, 'sum': 1416.0}, 'RA8-pos_3453': {'bp': 6554.0, 'sum': 14222.0}, 'QC6-pos_3396': {'bp': 3717.0, 'sum': 6015.0}, 'HC11-pos_3472': {'bp': 2664.0, 'sum': 5889.0}, 'HC12-pos_3623': {'bp': 2120.0, 'sum': 3547.0}, 'HC15-pos_3531': {'bp': 948.0, 'sum': 2221.0}, 'RA20-pos_3472': {'bp': 2083.0, 'sum': 3661.0}, 'HC5-pos_3554': {'bp': 22260.0, 'sum': 34797.0}, 'RA14-pos_3325': {'bp': 13991.0, 'sum': 24077.0}, 'HC18-pos_3409': {'bp': 35862.0, 'sum': 55341.0}, 'RA25-pos_3442': {'bp': 10648.0, 'sum': 17383.0}, 'RA12-pos_3720': {'bp': 11602.0, 'sum': 17766.0}, 'RA10-pos_3441': {'bp': 10717.0, 'sum': 23123.0}, 'HC6-pos_3499': {'bp': 14010.0, 'sum': 26199.0}, 'HC3-pos_3809': {'bp': 49500.0, 'sum': 79184.0}, 'RA3-pos_3440': {'bp': 27805.0, 'sum': 51907.0}, 'HC7-pos_3466': {'bp': 5086.0, 'sum': 7676.0}, 'HC19-pos_3403': {'bp': 5811.0, 'sum': 9228.0}, 'RA5-pos_3703': {'bp': 8970.0, 'sum': 14350.0}, 'RA4-pos_3577': {'bp': 8604.0, 'sum': 14357.0}}
COMMENT: RETENTION_TIME_STDEV 0.010
COMMENT: PRECURSOR_M/Z_RAW 385.341459
COMMENT: PRECURSOR_M/Z_STDEV 0.001055
COMMENT: PRECURSOR_IN_MS1 mz 385.343564; int 231.134; delta(ppm) 11.449119
COMMENT: PROPOSED_CHARGE_STATE +1; mz 386.346885; int 50.017; cor 0.976
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 7.231; C27H44O; [M+H]+; delta(ppm) -7.230644
COMMENT: PROPOSED_MF SevenGoldenRules 4.540; C21H45N4P; [M+H]+; delta(ppm) -4.540293
COMMENT: PROPOSED_MF SevenGoldenRules 3.237; C22H44N2O3; [M+H]+; delta(ppm) 3.236747
COMMENT: PROPOSED_MF SevenGoldenRules 13.702; C17H44N4O5; [M+H]+; delta(ppm) 13.701537
COMMENT: PROPOSED_MF MS-FINDER 3.591; C22H44N2O3; [M+H]+; delta(ppm) 3.226438
COMMENT: PROPOSED_MF MS-FINDER 3.581; C27H44O; [M+H]+; delta(ppm) -7.212879
COMMENT: PROPOSED_MF MS-FINDER 2.943; C15H44N8OS; [M+H]+; delta(ppm) 1.446719
COMMENT: PROPOSED_MF MS-FINDER 2.751; C18H40N8O; [M+H]+; delta(ppm) 10.195186
COMMENT: PROPOSED_MF MS-FINDER 2.353; C18H48N4S2; [M+H]+; delta(ppm) 11.410741
COMMENT: PROPOSED_MF SIRIUS5_Sirius 59.757; C22H44N2O3; [M+H]+; delta(ppm) 3.226438
COMMENT: PROPOSED_MF SIRIUS5_Sirius 11.143; C27H44O; [M+H]+; delta(ppm) -7.212879
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C22H44N2O3; [M+H]+; delta(ppm) 3.226438
COMMENT: PROPOSED_MF SIRIUS6_Sirius 62.957; C22H44N2O3; [M+H]+; delta(ppm) 3.226438
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.790; C20H42N5O2; [M+H]+; delta(ppm) 6.710800
COMMENT: PROPOSED_MF SIRIUS6_Sirius 29.872; C18H40N8O; [M+H]+; delta(ppm) 10.195186
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.808; C10H38N15O; [M+H]+; delta(ppm) -5.032825
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.312; C27H44O; [M+H]+; delta(ppm) -7.212879
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.102; C21H45N4P; [M+H]+; delta(ppm) -4.530732
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.551; C23H47NOP; [M+H]+; delta(ppm) -8.015016
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.789; C25H42N3; [M+H]+; delta(ppm) -3.728590
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.182; C8H36N18; [M+H]+; delta(ppm) -1.548520
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C22H44N2O3; [M+H]+; delta(ppm) 3.226438
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; OLDGKSQBWGEFNM-UHFFFAOYSA-N; C22H44N2O3; Lys-C16:0
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.124; IWKZTTDNVPAHNP-FQEVSTJZSA-N; [M+H]+; CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.989; OLDGKSQBWGEFNM-GNLPSFAGNA-N; [M+H]+; CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.701; JMVXLAWGZXLISM-LGMBCHCTNA-N; [M+H]+; CC(C)C#CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.693; QWRSWWMDQCPOTC-IUYVAJSCSA-N; [M+H]+; CC(C)\C=C\C[C@@H](C)C1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.685; DDABJYYWGWWMEN-UJOPKFNNSA-N; [M+H]+; CC(CC=CC(=C)C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.914; QYSXJUFSXHHAJI-MTCXXTJPNA-N; [M+H]+; Vitamin D3
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.812; UCTLRSWJYQTBFZ-LOPSNSAJNA-N; [M+H]+; 7-Dehydrocholesterol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.671; YUGCAAVRZWBXEQ-QEYGBBHESA-N; [M+H]+; Previtamin D3
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.665; AVSXSVCZWQODGV-ZMWIUTBPNA-N; [M+H]+; Desmosterol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.659; CGSJXLIKVBJVRY-XTGBIJOFSA-N; [M+H]+; Zymosterol intermediate 2
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.583; VUKORTMHZDZZFR-BXAZICILSA-N; [M+H]+; 8-Dehydrocholesterol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.561; PKEPPDGGTSZLBL-YVMWBMBONA-N; [M+H]+; 5a-Cholesta-7,24-dien-3b-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.558; NYOXRYYXRWJDKP-GYKMGIIDSA-N; [M+H]+; Cholestenone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.448; WMCFQVVNOGHBSE-HFWCXUSLNA-N; [M+H]+; UNPD147256
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.404; OLDGKSQBWGEFNM-GNLPSFAGNA-N; [M+H]+; UNPD42987
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.384; RZSXSHNNQBIPTL-HJWVNVQISA-N; [M+H]+; 5Alpha-cholesta-8-en-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.380; IWKZTTDNVPAHNP-FQEVSTJZSA-N; [M+H]+; (2S)-2-amino-6-(hexadecanoylamino)hexanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.255; XDJIBTPXDQQNLP-CEWCNFBSNA-N; [M+H]+; (7E)-(3S,6S)-6,19-cyclo-9,10-seco-5(10),7-cholestadien-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.254; ZPZNWLRQHDLNNV-XTWJGITRNA-N; [M+H]+; isotachysterol3
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.242; GGCLNOIGPMGLDB-GYKMGIIDSA-N; [M+H]+; cholest-5-en-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.217; QADVIPISOOQJMJ-AQEIDUOESA-N; [M+H]+; UNPD217384
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.211; KUSJXHNTXZIAEO-RRGFDOKANA-N; [M+H]+; UNPD195115
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.206; ZFEMKNUYYBDBGZ-DUGNHWPVNA-N; [M+H]+; UNPD12032
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.190; KIULDMFHZZHYKZ-ZMWIUTBPNA-N; [M+H]+; 4,6-cholestadienol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.188; XXELXWZVVFMNHA-AWXHMHFKNA-N; [M+H]+; toxisterol3 E1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.187; AWBZPJQUWZBRII-ZBNMSJAMNA-N; [M+H]+; 5alpha-cholesta-8,14-dien-3beta-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.180; QOXIONSEXNCZNL-HXPDYHFVNA-N; [M+H]+; toxisterol3 D1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.178; NYUOLQLVGBJSRN-CTXVPOMANA-N; [M+H]+; trisnor-Isoespinenoxide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.160; LMBGVVOJTGHJNP-HLFBDUQGNA-N; [M+H]+; (5E)-isovitamin D3 / (5E)-isocholecalciferol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.160; AGECEAALPZMKEA-OMTRETKFNA-N; [M+H]+; 3-Deoxy-25-hydroxyvitamin D3
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.155; TUHFOPXCGPVLBB-UHFFFAOYSA-N; [M+H]+; 1-(5,6-dimethylheptan-2-yl)-9a-methyl-1H,2H,3H,3aH,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.154; UPGTYLFCVNHBTN-OGPIFZCONA-N; [M+H]+; 22-Dehydrocholesterol;Cholesta-5,22-dien-3beta-ol;cis-22-Dehydrocholesterol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.152; YZGASHZUSKGPDO-LQYAFNHTNA-N; [M+H]+; (3S,6S)-9,10-seco-5(10),6,7-cholestatrien-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.138; UBEHHDQAQBJTAE-QMGBZBFANA-N; [M+H]+; 27-nor-(24R)-methylcholest-5,22E-dien-3beta-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.138; MOWNUYXUNULYGN-LDJPLTMONA-N; [M+H]+; UNPD44831
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.131; FLRPNSKUGCVRRB-UHFFFAOYNA-N; [M+H]+; 5alpha-Cholest-7-en-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.118; PFQBDFNRYUUEGP-UHFFFAOYSA-N; [M+H]+; CNP0441285
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.117; MEXFWGHHQDAONC-UHFFFAOYSA-N; [M+H]+; 9a,11a-dimethyl-1-(6-methylhepta-3,6-dien-2-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-7-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.112; MZGLFGZLQGCELA-VPZOQLPXSA-N; [M+H]+; UNPD227788
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.111; WMVOKVSGEZOLPP-HAEPZNAENA-N; [M+H]+; UNPD186361
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.103; KVLLAXYBNMUFSZ-WYWUKTBJNA-N; [M+H]+; UNPD112273
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.092; QWRSWWMDQCPOTC-IUYVAJSCSA-N; [M+H]+; 23-Dehydrocholesterol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.086; HKKMGGKMNHKQMC-PEFVFTJYNA-N; [M+H]+; UNPD9184
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.086; NWIFOPPNZLOPFJ-HPSROJQHNA-N; [M+H]+; UNPD130089
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.086; YMAJXDYECRDBBA-WTMXEFDENA-N; [M+H]+; UNPD109040
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.086; UNKZBWLOIRKUIE-UHFFFAOYSA-N; [M+H]+; 9a,11a-dimethyl-1-(6-methylheptan-2-yl)-1H,2H,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.085; GWHGZISYKVNRIM-XKRXJMMANA-N; [M+H]+; UNPD150350
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.081; UJELMAYUQSGICC-GZTMIQNGNA-N; [M+H]+; UNPD155950
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.079; HUJDFUNCWLFKGW-AJWXVUIZNA-N; [M+H]+; UNPD153879
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.079; ZPLQGWWDBWYRKB-CKNXYLOMNA-N; [M+H]+; UNPD132107
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.067; QQBZCLIYDXEZBI-AGRDSCIBNA-N; [M+H]+; 1alpha-hydroxy-3-deoxyvitamin D3 / 1alpha-hydroxy-3-deoxycholecalciferol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.054; NYSJXWPYXAOWLE-BEULGYNBNA-N; [M+H]+; (25S)-24S,26-cyclo-5alpha-cholestan-3beta-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.039; DDABJYYWGWWMEN-UJOPKFNNSA-N; [M+H]+; (3S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylhepta-4,6-dien-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.035; DDCFQFFSBXLAEV-UHFFFAOYSA-N; [M+H]+; 9a,11a-dimethyl-1-(5-methylhept-3-en-2-yl)-1H,2H,3H,3aH,5H,5aH,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-9-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.029; UROYYKVXZDFBPY-UHFFFAOYSA-N; [M+H]+; 1-(5,6-dimethylhept-3-en-2-yl)-11a-methyl-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.013; IIPHPVVRBVBREZ-ZXDCPUGRNA-N; [M+H]+; 1-(5alpha)-cholestenone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.005; VWYOARFPMUBYFG-ZTPZMMAUSA-N; [M+H]+; (8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-6-en-2-yl]-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.002; UYTUOBVSKUYFBB-DLLPOYASNA-N; [M+H]+; UNPD26595
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.998; KJOAIBPHMYWAOX-DBZATCLMNA-N; [M+H]+; UNPD121639
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.995; KQRCOBZIWSKXCB-QZYRKUIRNA-N; [M+H]+; 24,26-cyclocholesterol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.993; OZRGLPAXIYOWIG-HZPUXBNGSA-N; [M+H]+; (6R)-6-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.984; UPYVDXJUKQUZDF-OKNFQGGSNA-N; [M+H]+; UNPD163775
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.983; BWXPSPNRVJBBAK-VFNHYUHUNA-N; [M+H]+; 5, 20(22)-cholestadienol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.975; KQORTXDMJAMHQP-HHIWOQMPNA-N; [M+H]+; UNPD166350
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.937; DGMBRFFGNNFDAC-QJXJXLQINA-N; [M+H]+; Cystosterol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.922; JMVXLAWGZXLISM-LGMBCHCTNA-N; [M+H]+; UNPD120940
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.865; QHZGEIFOKNRJQD-RSRDUCJXNA-N; [M+H]+; Isoglaucanone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.832; PAFPYXSFFACISZ-UHFFFAOYSA-N; [M+H]+; 2,15-dimethyl-14-(6-methylheptan-2-yl)pentacyclo[8.7.0.0?,?.0?,?.0??,??]heptadecan-8-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.820; HZLDSDAIGDUPNB-UHFFFAOYSA-N; [M+H]+; 2,15-dimethyl-14-(6-methylheptan-2-yl)pentacyclo[8.7.0.0?,?.0?,?.0??,??]heptadecan-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; UCTLRSWJYQTBFZ-LOPSNSAJNA-N; [M+H]+; 7-Dehydrocholesterol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; IWKZTTDNVPAHNP-FQEVSTJZSA-N; [M+H]+; (2S)-2-amino-6-(hexadecanoylamino)hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.990; OLDGKSQBWGEFNM-GNLPSFAGNA-N; [M+H]+; UNPD42987
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.989; TUHFOPXCGPVLBB-UHFFFAOYSA-N; [M+H]+; 1-(5,6-dimethylheptan-2-yl)-9a-methyl-1H,2H,3H,3aH,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.988; KIULDMFHZZHYKZ-ZMWIUTBPNA-N; [M+H]+; 4,6-cholestadienol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.901; PFQBDFNRYUUEGP-UHFFFAOYSA-N; [M+H]+; CNP0441285
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.758; AGECEAALPZMKEA-OMTRETKFNA-N; [M+H]+; 3-Deoxy-25-hydroxyvitamin D3
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.756; QYSXJUFSXHHAJI-MTCXXTJPNA-N; [M+H]+; Vitamin D3
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.756; LMBGVVOJTGHJNP-HLFBDUQGNA-N; [M+H]+; (5E)-isovitamin D3 / (5E)-isocholecalciferol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.756; QQBZCLIYDXEZBI-AGRDSCIBNA-N; [M+H]+; 1alpha-hydroxy-3-deoxyvitamin D3 / 1alpha-hydroxy-3-deoxycholecalciferol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.756; XDJIBTPXDQQNLP-CEWCNFBSNA-N; [M+H]+; (7E)-(3S,6S)-6,19-cyclo-9,10-seco-5(10),7-cholestadien-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.734; YZGASHZUSKGPDO-LQYAFNHTNA-N; [M+H]+; (3S,6S)-9,10-seco-5(10),6,7-cholestatrien-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.724; QOXIONSEXNCZNL-HXPDYHFVNA-N; [M+H]+; toxisterol3 D1
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.714; AWBZPJQUWZBRII-ZBNMSJAMNA-N; [M+H]+; 5alpha-cholesta-8,14-dien-3beta-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.702; YUGCAAVRZWBXEQ-QEYGBBHESA-N; [M+H]+; Previtamin D3
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.702; ZPZNWLRQHDLNNV-XTWJGITRNA-N; [M+H]+; isotachysterol3
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.673; MZGLFGZLQGCELA-VPZOQLPXSA-N; [M+H]+; UNPD227788
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.488; JMVXLAWGZXLISM-LGMBCHCTNA-N; [M+H]+; UNPD120940
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.480; HKKMGGKMNHKQMC-PEFVFTJYNA-N; [M+H]+; UNPD9184
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.476; OZRGLPAXIYOWIG-HZPUXBNGSA-N; [M+H]+; (6R)-6-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.469; DDABJYYWGWWMEN-UJOPKFNNSA-N; [M+H]+; (3S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylhepta-4,6-dien-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.466; WMCFQVVNOGHBSE-HFWCXUSLNA-N; [M+H]+; UNPD147256
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.460; XXELXWZVVFMNHA-AWXHMHFKNA-N; [M+H]+; toxisterol3 E1
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.460; QADVIPISOOQJMJ-AQEIDUOESA-N; [M+H]+; UNPD217384
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.459; UYTUOBVSKUYFBB-DLLPOYASNA-N; [M+H]+; UNPD26595
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.458; MEXFWGHHQDAONC-UHFFFAOYSA-N; [M+H]+; 9a,11a-dimethyl-1-(6-methylhepta-3,6-dien-2-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.456; NYSJXWPYXAOWLE-BEULGYNBNA-N; [M+H]+; (25S)-24S,26-cyclo-5alpha-cholestan-3beta-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.456; GWHGZISYKVNRIM-XKRXJMMANA-N; [M+H]+; UNPD150350
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.454; MOWNUYXUNULYGN-LDJPLTMONA-N; [M+H]+; UNPD44831
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.453; CGSJXLIKVBJVRY-XTGBIJOFSA-N; [M+H]+; Zymosterol intermediate 2
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.453; PKEPPDGGTSZLBL-YVMWBMBONA-N; [M+H]+; 5a-Cholesta-7,24-dien-3b-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.452; UROYYKVXZDFBPY-UHFFFAOYSA-N; [M+H]+; 1-(5,6-dimethylhept-3-en-2-yl)-11a-methyl-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.452; KUSJXHNTXZIAEO-RRGFDOKANA-N; [M+H]+; UNPD195115
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.452; NWIFOPPNZLOPFJ-HPSROJQHNA-N; [M+H]+; UNPD130089
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.452; YMAJXDYECRDBBA-WTMXEFDENA-N; [M+H]+; UNPD109040
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.452; DDCFQFFSBXLAEV-UHFFFAOYSA-N; [M+H]+; 9a,11a-dimethyl-1-(5-methylhept-3-en-2-yl)-1H,2H,3H,3aH,5H,5aH,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-9-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.452; FLRPNSKUGCVRRB-UHFFFAOYNA-N; [M+H]+; 5alpha-Cholest-7-en-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.452; RZSXSHNNQBIPTL-HJWVNVQISA-N; [M+H]+; 5Alpha-cholesta-8-en-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.452; VUKORTMHZDZZFR-BXAZICILSA-N; [M+H]+; 8-Dehydrocholesterol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.451; AVSXSVCZWQODGV-ZMWIUTBPNA-N; [M+H]+; Desmosterol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.451; QWRSWWMDQCPOTC-IUYVAJSCSA-N; [M+H]+; 23-Dehydrocholesterol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.451; KQRCOBZIWSKXCB-QZYRKUIRNA-N; [M+H]+; 24,26-cyclocholesterol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.451; UBEHHDQAQBJTAE-QMGBZBFANA-N; [M+H]+; 27-nor-(24R)-methylcholest-5,22E-dien-3beta-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.450; BWXPSPNRVJBBAK-VFNHYUHUNA-N; [M+H]+; 5, 20(22)-cholestadienol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.449; KJOAIBPHMYWAOX-DBZATCLMNA-N; [M+H]+; UNPD121639
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.449; KVLLAXYBNMUFSZ-WYWUKTBJNA-N; [M+H]+; UNPD112273
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.449; UJELMAYUQSGICC-GZTMIQNGNA-N; [M+H]+; UNPD155950
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.449; ZFEMKNUYYBDBGZ-DUGNHWPVNA-N; [M+H]+; UNPD12032
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.448; UNKZBWLOIRKUIE-UHFFFAOYSA-N; [M+H]+; 9a,11a-dimethyl-1-(6-methylheptan-2-yl)-1H,2H,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.448; UPGTYLFCVNHBTN-OGPIFZCONA-N; [M+H]+; 22-Dehydrocholesterol;Cholesta-5,22-dien-3beta-ol;cis-22-Dehydrocholesterol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.444; ZPLQGWWDBWYRKB-CKNXYLOMNA-N; [M+H]+; UNPD132107
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.443; HUJDFUNCWLFKGW-AJWXVUIZNA-N; [M+H]+; UNPD153879
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.440; DGMBRFFGNNFDAC-QJXJXLQINA-N; [M+H]+; Cystosterol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.440; PAFPYXSFFACISZ-UHFFFAOYSA-N; [M+H]+; 2,15-dimethyl-14-(6-methylheptan-2-yl)pentacyclo[8.7.0.0?,?.0?,?.0??,??]heptadecan-8-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.432; VWYOARFPMUBYFG-ZTPZMMAUSA-N; [M+H]+; (8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-6-en-2-yl]-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.431; KQORTXDMJAMHQP-HHIWOQMPNA-N; [M+H]+; UNPD166350
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.431; NYOXRYYXRWJDKP-GYKMGIIDSA-N; [M+H]+; Cholestenone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.431; GGCLNOIGPMGLDB-GYKMGIIDSA-N; [M+H]+; cholest-5-en-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.431; IIPHPVVRBVBREZ-ZXDCPUGRNA-N; [M+H]+; 1-(5alpha)-cholestenone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.431; HZLDSDAIGDUPNB-UHFFFAOYSA-N; [M+H]+; 2,15-dimethyl-14-(6-methylheptan-2-yl)pentacyclo[8.7.0.0?,?.0?,?.0??,??]heptadecan-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.428; UPYVDXJUKQUZDF-OKNFQGGSNA-N; [M+H]+; UNPD163775
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.380; QHZGEIFOKNRJQD-RSRDUCJXNA-N; [M+H]+; Isoglaucanone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.168; NYUOLQLVGBJSRN-CTXVPOMANA-N; [M+H]+; trisnor-Isoespinenoxide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.159; WMVOKVSGEZOLPP-HAEPZNAENA-N; [M+H]+; UNPD186361
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.756; QYSXJUFSXHHAJI-YRZJJWOYSA-N; [M+H]+; (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.485; QKBXFGGCXRIBRO-UHFFFAOYSA-N; [M+H]+; methyl 3-[dimethylamino(hexadecanoyl)amino]propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; MXWVBGZSOBZROQ-ZDKIGPTLSA-N; [M+H]+; (Z,12R)-12-hydroxy-N-[2-(2-hydroxyethylamino)ethyl]octadec-9-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.801; UCTLRSWJYQTBFZ-DDPQNLDTSA-N; [M+H]+; (3S,9S,10R,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.494; LVKVIEXSVCMBJQ-UHFFFAOYSA-N; [M+H]+; [2-(ethylamino)ethyl-hexadecanoylamino] acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.119; YUGCAAVRZWBXEQ-FMCTZRJNSA-N; [M+H]+; (1S)-3-[(E)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.110; NYOXRYYXRWJDKP-GYKMGIIDSA-N; [M+H]+; (8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.088; KIULDMFHZZHYKZ-DPAQBDIFSA-N; [M+H]+; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.066; AVSXSVCZWQODGV-DPAQBDIFSA-N; [M+H]+; (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.960; VUKORTMHZDZZFR-BXAZICILSA-N; [M+H]+; (3S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.814; AWBZPJQUWZBRII-CXDHQSPESA-N; [M+H]+; (3S,5S,10S,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,11,12,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.802; ZPZNWLRQHDLNNV-QVEMQNNUSA-N; [M+H]+; (1S)-3-[(E)-2-[(1R,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.786; CGSJXLIKVBJVRY-XTGBIJOFSA-N; [M+H]+; (3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.783; GGCLNOIGPMGLDB-GYKMGIIDSA-N; [M+H]+; (8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.755; PKEPPDGGTSZLBL-FZAJRYLSSA-N; [M+H]+; (3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.752; RZSXSHNNQBIPTL-HJWVNVQISA-N; [M+H]+; (10S,13R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-1,2,4,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.652; FLRPNSKUGCVRRB-IINKENNYSA-N; [M+H]+; (5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,4,5,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.551; QWRSWWMDQCPOTC-IUYVAJSCSA-N; [M+H]+; (3S,10R,13R)-10,13-dimethyl-17-[(E,2R)-6-methylhept-4-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -21.998; OLDGKSQBWGEFNM; [M+H]+; n2-palmitoyl-l-lysine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -46.039; IWKZTTDNVPAHNP; [M+H]+; n6-palmitoyl-l-lysine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -118.297; BXEWSXCWIYPNGS; [M+H]+; N2,N2-Dimethyl-N6-(1-oxotetradecyl)-L-lysine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -152.556; MXWVBGZSOBZROQ; [M+H]+; Ricinoleic acid, aminoethylethanolamine condensate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.679; QKBXFGGCXRIBRO; [M+H]+; 3-(2,2-Dimethyl-1-hexadecanoylhydrazino)methylpropionate
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.481; OLDGKSQBWGEFNM; [M+H]+; n2-palmitoyl-l-lysine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -107.671; IWKZTTDNVPAHNP; [M+H]+; N6-Palmitoyl lysine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -120.203; OLDGKSQBWGEFNM; [M+H]+; 6-amino-2-hexadecanamidohexanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -216.821; BXEWSXCWIYPNGS; [M+H]+; N2,N2-Dimethyl-N6-(1-oxotetradecyl)-L-lysine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -321.866; GWDAEPLWBQKRBI; [M+H]+; 2-[Dimethyl-[3-(pentadecanoylamino)propyl]azaniumyl]acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -439.074; QKBXFGGCXRIBRO; [M+H]+; Hexadecanoic acid, 1-(3-methoxy-3-oxopropyl)-2,2-dimethylhydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -458.893; MXWVBGZSOBZROQ; [M+H]+; (Z)-12-Hydroxy-N-(2-((2-hydroxyethyl)amino)ethyl)-9-octadecenamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.506; IWKZTTDNVPAHNP; [M+H]+; N6-Palmitoyl lysine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C22H45N2O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(3), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 µm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 4.167
MS$FOCUSED_ION: PRECURSOR_M/Z 385.343713
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001i-9201000000-2b3d17735ffe41b0e5c7
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0494040 18.6586 56.049655 15.7718 9.72 0.7033 64 f{C3H6N1}/-1.28ppm,p-C19H39N1O3
  67.0540739 11.6439 67.054220 17.5828 8.64 0.4438 53 f{C5H7}/-2.28ppm,p-C17H38N2O3
  71.0853111 11.1099 71.085465 20.3840 8.37 0.5868 54 f{C5H11}/-3.03ppm,p-C17H34N2O3
  81.0694962 10.6210 81.069690 16.9238 9.27 0.4440 56 f{C6H9}/-4.69ppm,p-C16H36N2O3
  83.8252244 12.6763 83.825430 21.2704 7.96 0.6955 54 ?
  84.0804533 999.0000 84.080660 6.9219 0.00 0.9031 71 f{C5H10N1}/-3.83ppm,p-C17H35N1O3
  85.1014038 8.2311 85.101615 20.7635 4.32 0.5863 50 f{C6H13}/2.67ppm,p-C16H32N2O3
  95.0855025 12.1835 95.085760 19.1722 8.23 0.6585 58 f{C7H11}/-0.26ppm,p-C15H34N2O3
  109.1007098 11.2895 109.101040 13.5196 13.14 0.3692 53 f{C8H13}/-4.28ppm,p-C14H32N2O3
  112.0757933 9.0248 112.076140 14.8917 4.91 0.6890 51 f{C6H10N1O1}/0.92ppm,p-C16H35N1O2
  129.1025508 33.9308 129.103000 11.2933 14.63 0.7815 69 f{C6H13N2O1}/2.41ppm,p-C16H32O2
  130.0858744 154.7460 130.086330 7.4489 48.02 0.8790 71 f{C6H12N1O2}/-2.93ppm,p-C16H33N1O1
  147.1126580 98.5237 147.113230 9.3942 39.89 0.8509 71 f{C11H15}/-28.34ppm,p-C11H30N2O3
  322.3131635 38.8142 322.314055 11.5478 16.96 0.8837 70 f{C22H42O1}/-30.57ppm,p-H3N2O2
  324.3291630 39.5313 324.329970 11.3002 48.42 -0.0980 71 f{C22H44O1}/-29.30ppm,p-H1N2O2
  385.3445732 60.0074 385.346880 10.3388 25.94 1.0000 71 f{C22H45N2O3}/5.46ppm,p
PK$NUM_PEAK: 16
PK$PEAK: m/z int. rel.int.
  56.049404 18.66 18
  67.054074 11.64 11
  71.085311 11.11 11
  81.069496 10.62 10
  83.825224 12.68 12
  84.080453 999.00 999
  85.101404 8.23 8
  95.085502 12.18 12
  109.100710 11.29 11
  112.075793 9.02 9
  129.102551 33.93 33
  130.085874 154.75 154
  147.112658 98.52 98
  322.313164 38.81 38
  324.329163 39.53 39
  385.344573 60.01 60
//
